Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

The Salesforce-backed recruitment managemeent software provider was valued at $1.5bn in a round that pushed its overall funding past $200m.

TMRW Life Sciences is eyeing a global expansion of its frozen egg and embryo management services with new capital from investors including GV.

The NFT marketplace, which counts Coinbase, Animoca Brands and Gumi as investors, raised the funding in a series B round led by Andreessen Horowitz.

Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Nan Fung and Lam Research are set to exit the DNA sequencing technology developer in an $800m acquisition by market peer Pacific Biosciences.

Insight Partners and Tiger Global Management co-led a series C round valuing the Google, Slack and Intel-backed collaboration software provider above $2bn.

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

SoftBank, Circle and Coinbase Ventures were among more than 60 investors which funded the crypto exchange operator at an $18bn valuation.

Red Ventures has made a strategic investment in Tilting Point as part of the video game publishers’ first equity funding round.